Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 7,951 | 7,367 | 6,733 | 6,457 | 8,163 |
| Cost of Goods | 4,551 | 3,997 | 3,256 | 3,519 | 4,746 |
| Gross Profit | 3,400 | 3,370 | 3,477 | 2,938 | 3,420 |
| Operating Expenses | 12,487 | 12,905 | 11,533 | 11,922 | 16,104 |
| Operating Income | -8,536 | -8,538 | -7,800 | -8,465 | -11,941 |
| Other Income | 639 | 49 | 953 | 5,370 | -8,183 |
| Pre-tax Income | -7,897 | -8,489 | -6,847 | -3,095 | -20,124 |
| Income Tax | 36 | 14 | 10 | 7 | 1 |
| Net Income Continuous | -7,933 | -8,503 | -6,857 | -3,102 | -20,125 |
| Net Income | $-7,933 | $-8,503 | $-6,857 | $-3,102 | $-20,125 |
| EPS Basic Total Ops | -0.12 | -1.59 | -1.99 | -1.15 | -7.05 |
| EPS Basic Continuous Ops | -0.11 | -1.59 | -1.99 | -1.15 | -7.06 |
| EPS Diluted Total Ops | -0.12 | -1.59 | -1.99 | -1.15 | -7.05 |
| EPS Diluted Continuous Ops | -0.11 | -1.59 | -1.99 | -1.15 | -7.06 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.59 | -1.99 | -1.15 | N/A |
| EBITDA(a) | $-6,397 | $-6,347 | $-5,618 | $-6,222 | $-9,033 |